Table 3 The list of abbreviations
circRNAs | Circular RNAs |
|---|---|
RBPs | RNA-binding proteins |
CPIs | circRNA-RBP interactions |
ssRNAs | single-stranded RNAs |
RNA-seq | RNA sequencing |
ICC | Intrahepatic cholangiocarcinoma |
GC | Gastric cancer |
GBM | Glioblastoma multiforme |
PC | Prostatic cancer |
CML | Chronic myeloid leukemia |
EC | Endometrial cancer |
HCC | Hepatocellular carcinoma |
BCa | Bladder cancer |
RCC | Renal cell carcinoma |
CRC | Colorectal cancer |
OC | Ovarian cancer |
CC | Cervical cancer |
OS | Osteosarcoma |
TNBC | Triple-negative breast cancer |
CSCC | Cervival squamous cell carcinoma |
RB | Retinoblastoma |
NPC | Nasopharyngeal carcinoma |
NSCLC | Non-small cell lung cancer |
CLL | Chronic lymphocytic leukemia |
CRCC | Clear cell renal cell carcinoma |
LSCC | Laryngeal squamous cell carcinoma |
PDAC | Pancreatic ductal adenocarcinoma |
ESCC | Esophageal cell carcinoma |
CDDP | cisplatin |
HB | Hepatoblastoma |
HNSCC | Head and neck squamous cell carcinoma |
LUAD | Lung adenocarcinoma |
TOP1 | topoisomerase 1 |
DHX15 | DEAH box helicase 15 |
ATF3 | transcription factor 3 |
UPF1 | upstream frameshift 1 |
HDAC1 | histone deacetylase 1 |
hnRNPM | heterogeneous nuclear ribonucleoprotein M |
SRSF1 | Serine and Arginine Rich Splicing Factor 1 |
RBFOX2 | RNA-binding protein fox-1 homolog 2 |
TFRC | transferrin receptor protein 1 |
QKI | Quaking |
MBL | Muscleblind |
RNA pol II | RNA polymerase II |
IGF2BPs | Insulin-like growth factor 2 mRNA binding proteins |
PTBP1 | polypyrimidine tract-binding protein 1 |
CDCP1 | CUB-domain-containing protein 1 |
TXNIP | thioredoxin-interacting protein |
FUS | Fused in Sarcoma |
PD-L1 | programmed death ligand-1 |
p-STAT3 | phosphorylated STAT3 |
PTMs | post-translational modifications |
MEK1 | mitogen-activated protein kinase kinase 1 |
ceRNA | competitive endogenous RNA |
TME | tumor microenvironment |
SUMO | Small Ubiquitin-like Modifier |
EVs | extracellular vesicles |
SIM | SUMO-interacting motif |
ALIX | ALG-2 interacting protein X |
ELAVL1 | ELAV-like RNA-binding protein 1 |
GALNT3 | polypeptide N-acetylgalactosaminyltransferase 3 |
RBDs | RNA-binding domains |
RRM | RNA recognition motif |
KH | K-homology |
ZnF | Zinc finger domain |
hnRNPK | heterogeneous nuclear ribonucleoprotein K |
PABPs | poly(A) binding proteins |
ARMs | Armadillo/β-catenin-like repeat domains |
RBFOX2 | RNA-binding protein Fox-1 homolog 2 |
DBPs | DNA-binding proteins |
PAX | paclitaxel |
DDP | cisplatin |
FGF9 | Fibroblast Growth Factor 9 |
TME | tumor immune microenvironment |
MSH2 | MutS homolog 2 |
MIBC | muscle-invasive bladder cancer |
MATIIa, MAT2A | methionine adenosyltransferase IIa |
TKIs | Tyrosine kinase inhibitors |
ME1 | malate dehydrogenase 1 |
GRB7 | growth factor receptor-bound protein 7 |
FAK | focal adhesion kinase 1 |
ER | estrogen receptor |
ESR1 | estrogen receptor 1 |
IFN | type I interferon |
MAVS | mitochondrial antiviral signaling protein |
ceRNA | competitive endogenous RNA |
m6A | N6-methyladenosine |
RBDs | RNA-binding domains |
RNP | RNA-protein |
RIP-seq | RNA Immunoprecipitation Sequencing |
CLIP-seq | cross-linking immunoprecipitation sequencing |
ASOs | Antisense oligonucleotides |
